ANNAPOLIS, Md. — Governor Wes Moore today welcomed South Korea’s largest biotechnology company, Samsung Biologics, as they announced plans to open their first United States manufacturing facility in Rockville, Maryland. The announcement comes after Governor Moore and Maryland Department of Commerce Secretary Harry Coker met with Samsung Biologics executives earlier this year during an international trade and investment mission to Japan and South Korea to promote economic growth and workforce development.
“We are thrilled that Samsung Biologics has selected Maryland for their first U.S. manufacturing facility, a testament to our state’s leadership in life sciences, our highly-skilled workforce and the commitment of our private and public sector to advance patient health around the globe,” said Gov. Moore. “During our Asia trade mission, we were excited to share with Samsung Biologics executives the many reasons why Maryland is an ideal foothold from which the company can execute its long-term strategy to expand in the U.S. market.”
Samsung Biologics—headquartered in Seoul, South Korea—announced earlier this month that it has acquired GSK’s Rockville manufacturing facility for $280 million. The company plans to expand the site’s current drug substance capacity and upgrade the technology to support a growing demand for critical biologic medicines. As part of the acquisition, Samsung plans to retain more than 500 jobs currently at the site and create additional jobs, as well as new opportunities for local suppliers. The new U.S. facility will include expanded drug substance manufacturing capacity and will be able handle both clinical and commercial production…